Cogent Biosciences, Inc. (COGT) vs PTC Therapeutics, Inc. (PTCT)
A side-by-side comparison of Cogent Biosciences, Inc. and PTC Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COGT
Cogent Biosciences, Inc.
$30.33HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
PTCT
PTC Therapeutics, Inc.
$63.64HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — COGT vs PTCT
growth of $100 · dividends reinvested · last 9yCOGT -30.5% (-4.0%/yr)PTCT +99.4% (+8.0%/yr)PTCT compounded faster over this window
COGT PTCT
COGT vs PTCT: by the numbers
- •PTCT is the larger company ($5.31B vs $5.18B market cap).
- •Both run net losses; COGT's is the smaller (0.00% vs -3.80% net margin).
Metrics side by side
Valuation
| Metric | COGT | PTCT |
|---|---|---|
| Forward P/E | N/A | 50.08 |
| P/S ratio | N/A | 5.27 |
| P/B ratio | 11.08 | N/A |
| EV / EBITDA | N/A | 28.90 |
Profitability
| Metric | COGT | PTCT |
|---|---|---|
| Gross margin | 0.00% | 95.85% |
| Operating margin | 0.00% | 49.49% |
| Net margin | 0.00% | -3.80% |
| ROE | -70.85% | N/A |
| ROIC | -50.09% | 4.59% |
Growth (annualized)
| Metric | COGT | PTCT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 16.41% |
| Total return CAGR (5Y) | 28.51% | 11.75% |
Frequently asked
- How have COGT and PTCT total returns compared?
- Over the past 5 years, COGT delivered 28.51% and PTCT delivered 11.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cogent Biosciences ROEPTC Therapeutics ROECogent Biosciences operating marginPTC Therapeutics operating marginCogent Biosciences revenue growthPTC Therapeutics revenue growthCogent Biosciences free cash flowPTC Therapeutics free cash flow
Cogent Biosciences & PTC Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.